Biotech

Central Europe Genomics Center (CEGC) Engages Agent Alan Morell as Senior Advisor; Presented a 10 Figure Plus Term Sheet for Whole Genome Sequencing Servicing 500 Billion R&D Market of Central Europe

BEVERLY HILLS, CA: BEVERLY HILLS, CA -- (Marketwired) -- 11/03/16 -- Thursday, November 3, 2016) -Announced today, who will provide the 100M Central Europe Market with whole genome sequencing (WGS) technologies, acce ...

Trillium Therapeutics Announces Investor and Scientific Presentation Schedule for Remainder of 2016

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 11/03/16 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TR), a clinical stage immuno-oncology company developing innovative therapies for the treatment of canc ...

Bradmer Announces Third Quarter 2016 Financial Results

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 11/02/16 -- Bradmer Pharmaceuticals Inc. ("Bradmer" or the "Company") (NEX: BMR.H) today announced its third quarter 2016 financial results.F ...

Corcept Therapeutics Announces Third Quarter 2016 Financial Results and Provides Corporate Update

MENLO PARK, CA: MENLO PARK, CA -- (Marketwired) -- 11/01/16 -- Corcept Therapeutics Incorporated (NASDAQ: CORT)Third quarter revenue of $21.7 million, a 64 percent increase from the third quarter of 2015Third quarte ...

Theratechnologies Announces Update from its Healthcare Analyst Day Meeting

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 11/01/16 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced that it hosted a presentation with healthcare securities analysts in Toronto. Th ...

Microbix Appoints New Chief Financial Officer

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 11/01/16 -- Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, today announced that Charles Wallace, the Company's C ...

ANGLE plc: Notice of GM

GUILDFORD, UNITED KINGDOM: GUILDFORD, UNITED KINGDOM -- (Marketwired) -- 11/01/16 -- ANGLE plc (AIM: AGL) (OTCQX: ANPCY), the specialist medtech company, announces that a Notice of General Meeting (GM) has been distributed to ...

Theratechnologies: Results of HIV Biologic and Long-Acting Investigational Antiretroviral Ibalizumab to be Presented in Late-Breaker Session at IDWeek 2016(TM)

MONTREAL, CANADA: Phase III Study Primary Endpoint Results Show Ibalizumab Significantly Reduced Viral Load in Patients with Multi-Drug Resistant HIV-1 ...

Arch Biopartners Collaborates With Team at Cincinnati Veterans Affairs Medical Center to Prepare Phase I and II Human Trial Protocol and Application for AB569

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 10/27/16 -- Arch Biopartners, Inc., (Arch or the Company) (TSX VENTURE: ACH)(OTCBB: FOIFF) today announced it has agreed to sponsor Dr. Ralph Panos and his clini ...

S2G BioChem Announces Collaboration with Mondelez International for New Sweetener Process

VANCOUVER, BRITISH COLUMBIA: Production of Sustainably-Sourced Food Ingredient Xylitol Expected to Begin in 2018 ...